30-09-2022 16:30 via medpagetoday.com

Anti-BCMA-Based Regimen Impresses in Relapsed/Refractory Myeloma

(MedPage Today) -- Combination treatment with belantamab mafodotin (belamaf; Blenrep) plus lenalidomide (Revlimid) and dexamethasone appeared effective for relapsed or refractory multiple myeloma, and had a tolerable safety profile, according to...
Read more »